Sept 18 (Reuters) - Cardiovascular Systems Inc :Cardiovascular Systems announces anticipated revenue impact from hurricanes Harvey and Irma.Cardiovascular Systems - impact of hurricanes Harvey and Irma on procedure volumes in Greater Houstonm Florida will reduce fiscal 2018 Q1 revenues.Cardiovascular Systems -potential revenue impact on CSI quarterly results magnified due to "small product portfolio and location and timing of storms".Cardiovascular Systems - fiscal Q1 revenues are more heavily weighted in September, as procedure volumes begin to accelerate from summer levels.Cardiovascular Systems Inc - "Houston and Florida markets typically generate over 15% of CSI's revenues".Cardiovascular Systems - co anticipates that the factors will reduce Q1 revenues below range of $52.6 million to $53.6 million provided on August 2, 2017.
Sept 15 (Reuters) - T2 Biosystems Inc :T2 Biosystems announces pricing of public offering of common stock.Says public offering of 4.38 million common shares priced at $4 per share.
Sept 15 (Reuters) - Soleno Therapeutics Inc :Soleno Therapeutics presents updated safety and efficacy data from clinical trial of DCCR for treatment of Prader-Willi syndrome.Soleno Therapeutics Inc - phase iii study expected to begin by end of 2017.
Sept 15 (Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS> ::* Says it plans to boost capital of 3.1 million yuan into a Wuhan-based trading firm, in exchange for 51 percent stake .
Sept 15(Reuters) - Maccura Biotechnology Co Ltd <300463.SZ>:Says it plans to invest 10 million yuan to set up a wholly owned biotechnology unit in Shanghai.
Sept 14 (Reuters) - Lightpath Technologies Inc :Q4 revenue rose 90 percent to $9.0 million.Lightpath Technologies Inc qtrly earnings per share $0.24.Lightpath Technologies Inc - 12-month backlog was approximately $9.3 million at June 30, 2017, as compared to $6.6 million at June 30, 2016.
Sept 14 (Reuters) - LivaNova Plc :LivaNova Plc - Expects to achieve revenue growth in mid-single-digits in near term and high-single-digits in long term.LivaNova Plc - Anticipates compounded annual earnings per share growth in low- to mid-teens from 2017 to 2022.
Sept 15 (Reuters) - T2 Biosystems Inc :T2 Biosystems announces proposed public offering of common stock.
Sept 14 (Reuters) - EUROMEDIS GROUPE SA ::FY REVENUE EUR 73.6 MILLION VERSUS EUR 73.2 MILLION YEAR AGO.EXPECTS FY REVENUE FOR 2017/2018 OF EUR 80 MLN..
Sept 14 (Reuters) - SPINEGUARD SA ::SPINEGUARD REPORTS SIX-MONTH 2017 FINANCIAL RESULTS.H1 NET LOSS EUR 2.2 MILLION VERSUS LOSS OF EUR 2.5 MILLION YEAR AGO.H1 OPERATING LOSS IMPROVES BY 31% AND REDUCES TO EUR 1.5M.H1 REVENUE EUR 4.2 MILLION VERSUS EUR 3.6 MILLION YEAR AGO.